RxAll is a Deep Learning-Hyperspectral IoT Platform for the authentication and real-time global tracking of quality of drugs.
RxAll has raised $225K in total funding. The most recent round was Grant. The last funding was announced in April 2025.
RxAll's investors include Plug and Play, Launch Africa, LoftyInc Capital, SOSV, Merck.
RxAll is headquartered in New Haven, United States.
RxAll is a Deep Learning-Hyperspectral IoT Platform for the authentication and real-time global tracking of quality of drugs.
RxAll is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RxAll — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/rxall. Accessed November 13, 2026.
VCBacked. (2025). RxAll — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/rxall
{{cite web |title=RxAll — Funding & Investors |url=https://www.vcbacked.co/company/rxall |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at RxAll? Request a listing update